Abstract
This study described the drug release, rheological (dynamic and flow) and textural / mechanical properties of a series of formulations composed of 15% w / w polymethylvinylether-co-maleic anhydride (PMVE-MA), 0-9% w / w polyvinylpyrrolidone (PVP) and containing 1-5% w / w tetracycline hydrochloride, designed for the treatment of periodontal disease. All formulations exhibited pseudoplastic flow with minimal thixotropy. Increasing the concentration of PVP sequentially increased the zero-rate viscosity (derived from the Cross model) and the hardness and compressibility of the formulations (derived from texture profile analysis). These affects may be accredited to increased polymer entanglement and, in light of the observed synergy between the two polymers with respect to their textural and rheological properties, interaction between PVP and PMVEMA. Increasing the concentration of PVP increased the storage and loss moduli yet decreased the loss tangent of all formulations, indicative of increased elastic behaviour. Synergy between the two polymers with respect to their viscoelastic properties was observed. Increased adhesiveness, associated with increased concentrations of PVP was ascribed to the increasing bioadhesion and tack of the formulations. The effect of increasing drug concentration on the rheological and textural properties was dependent on PVP concentration. At lower concentrations (0, 3% w / w) no effect was observed whereas, in the presence of 9% w / w PVP, increasing drug concentration increased formulation elasticity, zero rate viscosity, hardness and compressibility. These observations were ascribed to the greater mass of suspended drug in formulations containing the highest concentration of PVP. Drug release from formulations containing 6 and 9% PVP (and 5% w / w drug) was prolonged and swelling / diffusion controlled. Based on the drug release, rheological and textural properties, it is suggested that the formulation containing 15% w / w PMVE-MA, 6% w / w PVP and tetracycline hydrochloride (5% w / w) may be useful for the treatment of periodontal disease.
Keywords: Tetracycline, bioadhesion, Polymer Networks Designed, PVP and PMVEMA
Current Drug Delivery
Title: Formulation and Characterisation of Tetracycline-Containing Bioadhesive Polymer Networks Designed for the Treatment of Periodontal Disease
Volume: 1 Issue: 1
Author(s): David S. Jones, Michelle S. Lawlor and A. David Woolfson
Affiliation:
Keywords: Tetracycline, bioadhesion, Polymer Networks Designed, PVP and PMVEMA
Abstract: This study described the drug release, rheological (dynamic and flow) and textural / mechanical properties of a series of formulations composed of 15% w / w polymethylvinylether-co-maleic anhydride (PMVE-MA), 0-9% w / w polyvinylpyrrolidone (PVP) and containing 1-5% w / w tetracycline hydrochloride, designed for the treatment of periodontal disease. All formulations exhibited pseudoplastic flow with minimal thixotropy. Increasing the concentration of PVP sequentially increased the zero-rate viscosity (derived from the Cross model) and the hardness and compressibility of the formulations (derived from texture profile analysis). These affects may be accredited to increased polymer entanglement and, in light of the observed synergy between the two polymers with respect to their textural and rheological properties, interaction between PVP and PMVEMA. Increasing the concentration of PVP increased the storage and loss moduli yet decreased the loss tangent of all formulations, indicative of increased elastic behaviour. Synergy between the two polymers with respect to their viscoelastic properties was observed. Increased adhesiveness, associated with increased concentrations of PVP was ascribed to the increasing bioadhesion and tack of the formulations. The effect of increasing drug concentration on the rheological and textural properties was dependent on PVP concentration. At lower concentrations (0, 3% w / w) no effect was observed whereas, in the presence of 9% w / w PVP, increasing drug concentration increased formulation elasticity, zero rate viscosity, hardness and compressibility. These observations were ascribed to the greater mass of suspended drug in formulations containing the highest concentration of PVP. Drug release from formulations containing 6 and 9% PVP (and 5% w / w drug) was prolonged and swelling / diffusion controlled. Based on the drug release, rheological and textural properties, it is suggested that the formulation containing 15% w / w PMVE-MA, 6% w / w PVP and tetracycline hydrochloride (5% w / w) may be useful for the treatment of periodontal disease.
Export Options
About this article
Cite this article as:
Jones S. David, Lawlor S. Michelle and Woolfson David A., Formulation and Characterisation of Tetracycline-Containing Bioadhesive Polymer Networks Designed for the Treatment of Periodontal Disease, Current Drug Delivery 2004; 1 (1) . https://dx.doi.org/10.2174/1567201043480027
DOI https://dx.doi.org/10.2174/1567201043480027 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Extracellular vesicles as drug delivery systems
Extracellular vesicles (EVs) are membranous vesicles released from almost all types of cells into extracellular space. EVs are categorized into different types including exosome (~30-150 nm), microvesicle or microparticle (~100-1,000 nm), apoptotic body (~1,000-5,000 nm), and others produced by different mechanisms. Since EVs bear the molecules (e.g., specific lipids, carbohydrates, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Therapeutic Properties of Natural Products Through the Expression of Heme Oxygenase-1
Mini-Reviews in Organic Chemistry Potential Mechanisms for Increased HIV-1 Transmission Across the Endocervical Epithelium During C. trachomatis Infection
Current HIV Research Sex Differences and Emerging New Risk Factors for Atherosclerosis and Its Thrombotic Complications
Current Pharmaceutical Design Therapeutic Targets for Management of Periodontitis and Diabetes
Current Pharmaceutical Design Biomimetic Oxidations of Xenobiotics by Metalloporphyrin and Salen Catalysts: Recent Applications
Current Catalysis Inhibitory Effects of 1,4-disubstituted Thiosemicarbazide Derivatives on Streptococcus mutans and Streptococcus sanguinis Mono-species Biofilms
Letters in Drug Design & Discovery Linking Antimicrobial Potential of Natural Products Derived from Aquatic Organisms and Microbes Involved in Alzheimer’s Disease - A Review
Current Medicinal Chemistry The Economics of Pharmacogenomics
Current Pharmacogenomics Population Approaches for Detecting Glucose Disorders
Current Diabetes Reviews Microbial Polysaccharides and their Derivatives as Current and Prospective Pharmaceuticals
Current Pharmaceutical Design Recent Patents in Bone Graft Substitute for Bone, Tendon, and Ligament Reconstruction
Recent Patents on Biomedical Engineering (Discontinued) Medical Complications in Anorexia and Bulimia Nervosa
Endocrine, Metabolic & Immune Disorders - Drug Targets Local Drug Delivery Based Treatment Approaches for Effective Management of Periodontitis
Current Drug Therapy Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Stem Cell and Regenerative Medicine
Current Stem Cell Research & Therapy Asiaticoside Enhances the Osteoblast Potential of LPS-induced Periodontal Ligament Stem Cells through TLR4/NF-κB Pathway
Letters in Drug Design & Discovery ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Central Regulatory Role of Cytokines in Periodontitis and Targeting Options
Current Medicinal Chemistry Tissular Senescence and Modifications of Oral Ecosystem in the Elderly: Risk Factors for Mucosal Pathologies
Current Aging Science A Short Overview on the Biomedical Applications of Silica, Alumina and Calcium Phosphate-based Nanostructured Materials
Current Medicinal Chemistry